Mastelli’s approach to the management of acute and chronic skin wounds is based on the use of original and natural raw materials extracted by means of a peculiar method that produce a synergic action for accelerating healing of wounds, ulcers, bedsores and burns.
DRUGS /MEDICINAL PRODUCTS
Placentex®
containing Polydeoxiribonucleotides PDRN, a pharmaceutical active ingredient
- Placentex® “5,625 mg/3 ml injectable solution” 5 x 3 ml ampoules;
- Placentex® “2,25 mg/3 ml injectable solution” 5 x 3 ml ampoules;
- Placentex® “0,75 mg/3 ml skin solution” 10 x 3 ml ampoules;
- Placentex® “0,08% cream” 25 g tube.
For an up-to-date Summary of Product Characteristics (SPC) and Information Leaflet (IL), refer to the site of AIFA (Agenzia Italiana del Farmaco, the Italian Medicines Agency).
MEDICAL DEVICES
Nucliaskin® Line Class III MD CE0373
Containing Polynucleotides HPT and Hyaluronic Acid
Nucliaskin® S
Gel containing Polynucleotides HPT e Hyaluronic Acid. Advanced medication for the treatment of ulcers and skin lesions – 2 ml pre-filled syringe
Nucliaskin® Oral Care
Protective gel for the oral mucosa containing Polynucleotides HPT and Hyaluronic Acid. The gel promotes the reparative processes in the event of aphthae or lesions – 15 g tube
THERAPEUTIC AREAS
